Leggio, Lorenzo http://orcid.org/0000-0001-7284-8754
Hendershot, Christian S. http://orcid.org/0000-0002-5328-2035
Farokhnia, Mehdi http://orcid.org/0000-0003-0902-4212
Fink-Jensen, Anders http://orcid.org/0000-0001-7143-1236
Klausen, Mette Kruse http://orcid.org/0000-0002-9300-470X
Schacht, Joseph P.
Simmons, W. Kyle http://orcid.org/0000-0002-0399-9003
Funding for this research was provided by:
U.S. Department of Health ; Human Services | National Institutes of Health
U.S. Department of Health ; Human Services | National Institutes of Health
U.S. Department of Health ; Human Services | National Institutes of Health
Novo Nordisk Fonden
Novo Nordisk Fonden
Region Hovedstaden
U.S. Department of Health ; Human Services | National Institutes of Health
U.S. Department of Health ; Human Services | National Institutes of Health
Article History
First Online: 24 November 2023
Competing interests
: L.L. reports, outside his federal employment, honoraria from the UK Medical Council on Alcohol (editor-in-chief for <i>Alcohol and Alcoholism</i>) and book royalties from Routledge (as editor of a textbook). A.F.J. has received two unrestricted research grants from Novo Nordisk A/S for two clinical studies investigating the effects of GLP-1RAs in antipsychotic-treated prediabetic patients with schizophrenia. J.P.S. has received study medication from Bausch Health. The other authors report no competing interests.